AVAC has identified dashboards, data trackers and other resources to inform your advocacy with critical data.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
View this email in your browser
AVAC Advocates' Network Logo April 14, 2025

Despite USG Global Health Collapse, Here Are Several Data Trackers To Support Your Advocacy

Dear Advocate,

With the collapse in support from the US Presidential administration in global health, data sources tracking the HIV response have been lost, from HIV incidence and prevalence to PrEP uptake and disparities among key populations and regions of the world. Below, AVAC has identified dashboards, data trackers and other resources to inform your advocacy.

Tracking PrEP Access
 

Impact of the Stop-Work Order on PrEP

On PrEPWatch, this webpage outlines the consequences of PEPFAR stop-work orders on HIV prevention, detailing disruptions to PrEP services, stalled product rollouts (including CAB), halted research, and workforce reductions. It includes downloadable slides to support advocacy and analysis.

Tracking Lenacapavir Rollout

This new online tracker monitors all the key steps, timelines and responsible stakeholders needed to ensure equitable access to injectable lenacapavir (LEN) for PrEP. Find it on PrEPWatch.

Tracking the Impact of USG Funding Cuts
 

Tracking the Freeze: Real-Time Impact on Key Populations

The Global Black Gay Men Connect (GBGMC) network, with more than 150 partners across regions, is tracking the immediate and devastating effects of USG freeze on foreign assistance. This page compiles verified data from the field and updates it weekly.

PEPFAR Funding Freeze

This webpage shares resources developed by a new global civil society coalition, Community Health and HIV Advocates Navigating Global Emergencies (CHANGE) on various impacts of the freeze.

Impact of Partial PEPFAR Funding Freeze and Discontinuation: Estimated Deaths

Impact Counter’s tracker reflects the estimated number of deaths that have occurred between January 24, 2025, and today, as a result of the partial funding discontinuation. (See also Medicaid Impact Counter & Tuberculosis Impact Tracker.)

Impact of US Funding Cuts on the Global AIDS Response

UNAIDS’ weekly situation report provides an overview and up-close country snapshots of the impact to service delivery and human resources.

The Best Investment You Didn’t Know You Made

HIV Market Impact Memo

This brief from CHAI shares significant risks facing global HIV markets and the broader implications for HIV service delivery in LMICs following global health funding disruptions and ongoing uncertainty.

The USAID List of Terminated Global Health Awards – What Does it Tell Us?

This resource from KFF shares a list of USAID awards and their status—either active or terminated.

Tracking Court Action
 

Litigation Tracker: Legal Challenges to Trump Administration Actions

JustSecurity.org tracks legal challenges to the administration’s actions.

AVAC V. United States Department of State

AVAC’s dedicated page shares updates on the case against the US government seeking emergency relief from an Executive Order that inhumanely froze all funding for foreign assistance. Our latest episode of PxPulse Live, Lawsuit Wins and What’s at Stake: AVAC v US Department of State offers context and updates.

These trackers and additional resources are included in our weekly Global Health Watch newsletter along with the latest policy developments and their implications to keep advocates informed, prepared and connected.

Best,

AVAC

Follow us @hivpxresearch
Follow us on Facebook Follow us on BlueSky Follow us on YouTube
Share this issue
AVAC Global Advocacy for HIV Prevention
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences  |  Unsubscribe